Rejuvenate Biomed
Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing. By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.
1
Funding Rounds
$15.7m
Money raised
Overview
Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing. By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.
- Website:
Funding series
Funding Series Analysis
The company Rejuvenate Biomed has raised a total of $15.7m in funding over 1 rounds.
Key Insights:
- Rejuvenate Biomed Series B round, October 2021: $15.7m
Rejuvenate Biomed Series B round, October 2021
$15.7m
Industries
Rejuvenate Biomed is active in the following industries: